Use access key #2 to skip to page content.
$2.36 -0.12 (-4.84%)
10/7/2008 4:11 PM

Theragenics Corp (TGX)

CAPS Rating:
***

A medical device company serving the cancer treatment and surgical markets. The Company produces, markets and sells TheraSeed(r), its premier palladium-103 prostate cancer treatment device and I-Seed, its iodine-125 based prostate cancer treatment device.

View All Commentary (TGX)

Recs

0

Avatar 5cottlee (71.52) Submitted: 5/02/08 3:53 PM : Underperform Start Price: $3.69 TGX Score: 6.94

I don't know why but I just hate this stock.

Report this Post Replies: 0 | Reply

Featured Broker Partners